Science Magazine | AAAS: Science Translational Medicine Follow EGFR inhibition down-regulates MGMT and enhances responsiveness to temozolomide in glioblastoma | Science Translational Medicine Inhibiting EGFR before treatment with temozolomide enhances its efficacy in experimental models of glioblastoma. https://www.science.org/doi/10.1126/scitranslmed.adx8398 science.org
